✦ LIBER ✦

Sa1918 Better off Naïve: Predictors of Adalimumab Dose Escalation in Patients With Crohn's Disease

✍ Scribed by Moncrief, Karli; Steinhart, A. Hillary; Croitoru, Ken; Newman, Alvin; Nguyen, Geoffrey C.; Xu, Wei; Silverberg, Mark S.

Book ID: 122126623
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 122 KB
Volume: 142
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(12)61353-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of adalimumab dose escalation

Predictors of adalimumab dose escalation in patients with crohn's disease at a tertiary referral center

✍ Russell D. Cohen; Jeffrey R. Lewis; Hannah Turner; Laura E. Harrell; Stephen B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

Background: Pivotal trials for adalimumab (ADA) demonstrated effectiveness versus placebo for induction and maintenance of remission in moderate to severely active Crohn's disease (CD). Although the approved maintenance regimen in the U.S. is 40 mg subcutaneously every 14 days, some patients require

Predictors of dose escalation of adalimu

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients

✍ E. Bultman; C. de Haar; A. van Liere-Baron; H. Verhoog; R. L. West; E. J. Kuiper 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

W1093 Predictors and Timing of Adalimuma

W1093 Predictors and Timing of Adalimumab (ADA) Dose Escalation in Patients with Crohn's Disease (CD)

✍ Cohen, Russell D.; Lewis, Jeffrey R.; Turner, Hannah; Hanauer, Stephen B.; Rubin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Adalimumab dose escalation and dose de-e

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

✍ Baert, Filip; Glorieus, Elien; Reenaers, Cathérine; D'Haens, Geert; Peeters, Har 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 446 KB

Temporary adalimumab dose escalation is

Temporary adalimumab dose escalation is effective in Crohn's disease patients with secondary non-response

✍ Sutharshan, K.; Gearry, R.B. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 242 KB

Long-term efficacy of adalimumab in Paed

Long-term efficacy of adalimumab in Paediatric Crohn's disease patients naïve to other anti-TNF therapies

✍ J. Martín-de-Carpi; N. Pociello; V. Varea 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 177 KB